APA

Hillmen P., Cohen D. R., Cocks K., Pettitt A., Sayala H. A., Rawstron A. C., Kennedy D. B., Fegan C., Milligan D. W., Radford J., Mercieca J., Dearden C., Ezekwisili R., Smith A. F., Brown J., Booth G. A., Varghese A. M. & Pocock C. (20110512). A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. : British journal of haematology.

Chicago

Hillmen Peter, Cohen Dena R, Cocks Kim, Pettitt Andrew, Sayala Hazem A, Rawstron Andy C, Kennedy Daniel B, Fegan Christopher, Milligan Don W, Radford John, Mercieca Jane, Dearden Claire, Ezekwisili Raphael, Smith Alexandra F, Brown Julia, Booth Gillian A, Varghese Abraham M and Pocock Christopher. 20110512. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. : British journal of haematology.

Harvard

Hillmen P., Cohen D. R., Cocks K., Pettitt A., Sayala H. A., Rawstron A. C., Kennedy D. B., Fegan C., Milligan D. W., Radford J., Mercieca J., Dearden C., Ezekwisili R., Smith A. F., Brown J., Booth G. A., Varghese A. M. and Pocock C. (20110512). A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. : British journal of haematology.

MLA

Hillmen Peter, Cohen Dena R, Cocks Kim, Pettitt Andrew, Sayala Hazem A, Rawstron Andy C, Kennedy Daniel B, Fegan Christopher, Milligan Don W, Radford John, Mercieca Jane, Dearden Claire, Ezekwisili Raphael, Smith Alexandra F, Brown Julia, Booth Gillian A, Varghese Abraham M and Pocock Christopher. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. : British journal of haematology. 20110512.